Kummer, J
The first drug that came on the market, Victoza, was based on the GLP-1 sequence I discovered
Retatrutide Dosing (Trial-Based Structure Only) The only available retatrutide dosing information comes from published clinical trials
For Medicare members with established cardiovascular disease who are overweight or obese, the cardiovascular risk reduction indication is coverable under Part D with prior authorization
The same day the tirzepatide decision was released, the FDA posted that it continues to actively monitor drug availability and is currently working to determine whether the demand or projected demand for each drug in shortage, including semaglutide, exceeds the available supply. An update in the back-and-forth between the FDA and compounder associations, which sued the FDA when they first lifted the shortage in October, is due later this week
Any consideration of GLP-1 therapy should involve comprehensive evaluation by an endocrinologist or appropriate specialist, with clear discussion of the investigational nature of this approach, potential risks, costs, and the importance of ongoing monitoring